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In conclusion: Pts traditionally considered thrombolytic eligible comprise a
low risk cohort, and have a favorable prognosis whether treated with primary
PTCA or t-PA. In contrast, pts historically excluded from most early lytic trials
because of advanced age, late presentation or prior CABG are at increased
risk, and may have improved survival with primary PTCA rather than throm-
bolysis.
Exercise Training in Postinfarction Patients with
Left Ventricular Dysfunction. Preliminary
Results of the Exercise in Left Ventricular
Dysfunction (ELVD) Trial
Differential Effects of Long-term Beta-Blocker
Therapy Following Thrombolysis versus
Primary Angioplasty
Follow-up Events Propranolol Placebo p-value
In = 317) (n = 339) (Cox regression)
Overall mortality 7.6% 13.6% 00078
Sudden death 4.7% 9.7% 00094
Definite or probable MI 3.8% 7.7% 0.037
MI andlor mortality 9.2% 17.4% 0.0011
ocardial infarction (AMI) who have persistent electrocardiographic (ECG) ST
segment depression (STD) are at high risk for future cardiac events when
compared with AMI pts without STD. There are little data on the long term
effects of medical therapy on acute MI pts with STD. The objectives of this
retrospective analysis were to examine in the Beta Blocker Heart Attack Trial
(BHAT) the effects of propranolol in this high risk group. Of the 2877 first MI
BHAT pts, 656 pts had persistent ECG STD from the time of admission until
randomization (9.7 ± 3.1 days after index MI). Of these, 317 pts were ran-
domized to the propranolol and 339 pts to placebo. There were no significant
baseline differences (p < 0.05) between the two groups. The median follow
up was 24.6 months.
Cox regression analysis, adjusting for baseline variables showed the rel-
ative risk of mortality and the relative risk of sudden death were 2.13 (1.22,
3.70) and 2.56 (1.27, 5.26) respectively in the placebo, compared to the pro-
pranolol group. It appears that propranolol therapy is effective in reducing
cardiac events in pts recovering from an AMI with ECG STD.
Raffl K. Krikorian, Sylvia B. Puchrowicz, James H. O'Keefe, Jr., Cindy L. Crines,
Kevin F. Browne, Donald Rothbaum, Ronald E. Vlietstra, Gregg W. Stone, William
W. O'Neill. Mid America Heart InsMute, Kansas City, MO; Beaumont Hospital, Royal
Oak,MI
The effects of chronic beta-blocker therapy (BBT) following reperfusion ther-
apy for myocardial infarction IMI) are unclear. To address this question, we
evaluated the long-term effects of BBT on patients (pts) in the PAMI study.
A total of 395 pts were raandomized to thrombolysis (t-PA) or primary angio-
plasty (PTCA); 20 pts (5%) were lost to follow-up. Mean follow-up averaged
24 months. 42% of pts in both groups received long-term BBT. The groups
with BBT I$BBT) and without BBT (8BBT) for both PTCA and t-PA treated
arms were similar with respect to age, gender, ejection fraction, hyperten-
sion, diabetes, lipids, smoking, etc.
Pantaleo Giannuzzi, Pier L. Temporelli, Marinella Gattone, Ugo Corra,
Amerigo Giordano, Luigi Tavazzi, ELVD Study Group. Clinica del uworo Foundation,
IRCCS, Cardiology Department, Veruno, Italy
Aim of this multicenter randomized study was to investigate whether long-
term physical training would influence left ventricular remodeling and func-
tion in patients (pts) with systolic dysfunction after myocardial infarction (MI).
Forty-three consecutive pts (51 ± 8 years) with :0:40% ejection fraction (EF)
and no contraindications to exercise, in I-II NYHA Class, were studied 3-5
weeks after a first Q-wave M I and 6 months later by 2D-ECHO at rest and
upright symptom-limited bicycle ergometric test. After the initial study, pts
were randomly allocated to a 6-month exercise training program (T. n 22)
or control (C, n 21). A computerized system was used to derive echocar-
diographic variables of ventricular size, function and topography. At entry,
work capacity (WC). end-diastolic (EDV) and end-systolic (ESV) volumes, EF,
extent of wall motion abnormalities (%WMA) and regional dilatation (%RD)
were similar in the two groups. After 6 months, a significant increase in WC
was observed only in T (from 4,527 ± 1,107 to 5,529 ± 1,828 Kp-m, p < 0.01)
and not in C (from 4,371 ± 1,143 to 4,268 ± 1,199 Kp-m, NS), whereas LV
volumes and %RD increased in C IEDV: from 86 ± 24 to 95 ± 29 ml!m2, p
< 0.01; ESV: from 58 ± 21 to 66 ± 26 ml/m2 , p < 0.01; %RD: from 47 ± 18
to 57 ± 22, p < 0.01) but not in T IEDV: from 84 ± 21 to 85 ± 22 ml!m2, NS;
ESV: from 56 ± 17 to 54 ± 19 ml!m2, NS; %RD: from 43 ± 18 to 45 ± 26,
NS). Conversely, %WMA decreased and EF improved in T (%WMA: from 48
± 8 to 43 ± 10, P < 0.01; EF: from 34 ± 5 to 38 ± 8%, P < 0.01), but not in
C (%WMA: from 47 ± 9 to 48 ± 12, NS; EF: from 33 ± 5 to 32 ± 7%, NS).
Thus, from these preliminary data it appears that in postinfarction pts with
poor left ventricular function long-term exercise training may attenuate the
unfavorable remodeling response and even improve both global and regional
function over time.
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Stress Echo and the Risk of Reinfarction: A
Fatal Attraction?
Thrombolytic eligible Thrombolytic ineligible
PTCA l-PA P PTCA t-PA P
In = 1271 In = 117) (n = 68) In = 831
in-hosp. D 2.4% 1.7% NS 2.9% 13.3% 0.025
in-hosp. D or R 5.5% 9.4% NS 4.4% 15.7% 0.026
in-hosp. RIE 11.8% 29.1% 0.0008 7.4% 26.6% 0.002
in-hasp. stroke 0% 1.7% NS 0% 6.0% 0.04
6 month D 3.9% 1.7% NS 2.9% 15.7% 0.009
6 month D or R 8.7% 12.8% NS 7.4% 22.9% 0.009
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traditionally considered lytic "eligible" vs. "ineligible" (age> 70, MI onset >4
hours, or prior CABG). we examined the PAMI database in which 395 pts of
any age within 12 hours onset of MI were randomized tot-PA or primary PTCA
(pts with shock were excluded). Compared to lyric eligible pts, ineligible pts
were 01der(67 vs. 56 yrs, p < 0.0001). more frequently female (38% vs. 20%,
P < 0.00011. diabetic (17% vs. 10%, P = 0.03), had prior CABG (8% vs. 0%,
P < 0.0001). presented later (4.4 vs. 2.2 hours, p < 0.0001), and were more
likely to present in CI-1F (20% vs. 11%, P = 0.01). Endpoints included death
(D), reinfarction (R). recurrent ischemic events (RIE) and stroke:
Rosa Sicari, Alessandro Pingitore, Giovanni Minardi, Nicola Gandolfo,
Giovanni Seveso, Francesco Chiarella, Leonardo Bolognese, Giacomo Chiaranda,
Nunzia Petix, Maria Grazia Sciavo, Mario Previtali, Franca Margaria, Omelia Magaia,
Federico Bianchi, Salvatore Pirelli, Luis Felipe de Moura Duarte, Maria Jose de
Sousa, Silva Severi, Mauro Raciti, Patrizia Landi, Eugenio Picano, EPIC (Echo
Persantine Italian Cooperative) study group. CNR, Institute of Clinical Physiology.
Pisa, Italy
The identification of future reinfarction seems an elusive target for physio-
logic testing, consistently with the accepted notion that it is plaque type,
rather than plaque size, that matters in provoking coronary occlusion. How-
ever, large sample populations are needed to detect phenomena with a low
event rate. In addition, one should employ noninvasive stress test results
that are tightly related to the extent and severity of CAD - in a stronger way
than exercise-ECG. Aim of this study was to assess the capability of dipyri-
damole echocardiography test (DET) to predict reinfarction in patients eval-
uated early after acute uncomplicated myocardial infarction. In an updated
analysis of the EPIC Study, we assessed the value of DET in predicting rein-
farction in 1080 pts (age = 56 ± 9, 926 men and 154 women) evaluated early
(10 ± 5 days) after uncomplicated acute myocardial infarction and followed
up for 14 ± 10 months. A positive test occurred in 475 pts (44%). During
follow-up, there were 50 reinfarctions: 45 non-fatal, and 5 fatallfollowed by
cardiac death after :0:4 days from the reinfarction). Reinfarction (either non-
fatal or fatal) occurred in 30 pts with positive and in 20 with negative DET
(6.3 vs 3.3%, p < 0.01). Nonfatal reinfarction occurred in 25 patients with
positive and in 20 with negative DET (5 vs 3%, P = 0.05). Reinfarction was
fatal in 5 out of 25 reinfarcted patients with positive and in none out of 20
reinfarcted patients with negative DET (20 vs 0%, P = 0.07). The relative risk
li.e., the relative risk of the occurrence of future cardiac events in the group
with negative DET) of reinfarction was 1.9.
In conclusion, DET positivity identifies patients evaluated early after un-
complicated myocardial infarction at higher risk of reinfarction and especially
of fatal reinfarction.
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Effects of Propranolol in Patients with Their
First Acute Myocardial Infarction and Persistent
Electrocardiographic ST Segment Depression
in the Beta Blocker Heart Attack Trial
Kalyanam Shivkumar, Lonni Schultz, Sidney Goldstein, Mihai Gheorghiade. Henry
Ford Heart and Vascular Institute, Detroit, MI; Northwestern University Medical School,
Chicago,lL
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The available data suggest that patients (pts) recovering from an acute my-
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Events during follow-up
Death Recurrent Ischemia
lower transvalvular pressure gradients little benefit in exercise performance
is achieved with p-blocker therapy in patients with moderately severe mitral
stenosis.
Multivariate analysis identified BBT as an independent predictor of long-
term survival in the t-PA arm, but not the PTCA arm. In PTCA pts, BBT was
a univariate predictor of the combined end point of freedom from death,
infarction, heart failure and dysrhythmias.
Conclusion: BBT appears to provide significant beneficial effects during
long-term follow-up after t-PA for acute MI; these benefits were less impres-
sive and not statistically significant in the PTCA-treated patients.
Leszek Ceremuiynski 1, Andrzej Budaj, Wanda Smielak-Korombel, Jerzy Kuch,
Maria Krzeminska-Pakula, Janusz Maciejewicz, Edmund Nartowicz, Teresa Zaleska,
Andrzej Dyduszynski, Piotr Kokowicz, collaborating centers of Polish Amiodarone
Trial. 1Postgraduate Medical School, Grochowski Hospital, Warsaw. PI
The Polish Amiodarone Trial revealed significant reduction of l-year cardiac
mortality with low-dose Amiodarone (Am) after MI. To assess whether this
beneficial effect persisted, the long-term outcomes of the pts of the Am
treated group (n = 305) and ofthe control group (C) (n = 309) were assessed.
The probability of cardiac death after 12 and 46 months according to
Kaplan-Meier curves was respectively Am 6.2,17.4% and C 10.7, 19.5%.
The curves after 12 months remained parallel.
The comparison of 25 pts treated continuosly for 46 months with Am
and 189 C pts not treated with Am revealed significant difference in survival
curves in favour of Am treated group (p = 0.04).
Side effects occurred in 3 of 25 pts treated with Am during long-term
follow-up.
Beneficial effect of one year Am treatment on survival after Mi persists for
the next three years. The prolongation of therapy is feasible and diminishes
the risk of cardiac death.
Long-term Secondary Prevention After
Myocardial Infarction with Amiodarone
We conclude 1) PMC with IN provides better immediate results than DB.
mainly because of a tendency towards less frequent severe MR. 2} Never-
theless, no difference in functional results is apparant at 2 years,
p
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Comparison of Immediate and Mid-term Results
Following Percutaneous Mitral Commissurotomy
with the Inoue Stepwise Technique and with the
Double-Balloon Technique
Long Term (6 year) Outcome After Catheter
Balloon Valvuloplasty in Patients with Mitral
Stenosis
Increase in VA (2D echo) (cm2)
MR '" 314 (Sellers) (%)
Good immediate results (%)
Good results at 2 years (%)
1 1024-771
Bernard lung, Bertrand Cormier, Olivier Nallet. Jean-Marc Porte,
Pierre-Louis Michel, Jean Acar, Alec Vahanian. Tenon Hospital. Paris. France
Immediate and mid-term results of percutaneous mitral commissurotomy
(PMC) were compared following the use of the Double-Balloon technique
(DB) and the Inoue stepwise technique (IN) under echo-guidance. Between
1986 and 1994, 1228 patients (pts) underwent PMC in our department. 586
pts with DB and, more recently, 642 pts with IN.
Before PMC, no significant difference was found between the two groups
as regards clinical or echocardiographic or hemodynamic data.
Good immediate results were defined as a final valve area (VA) ~1.5 cm2
without mitral regurgitation (MR) >2/4. Good results at 2 years were defined
as survival without operation and with continuing good functional results
INYHA class I or II}.
Results were as follows:
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36/91140%)
1/69 (1.4%)
19/94 (20.2%)
5/67 (7.5%)
9/91 (9.9%)
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Beta-Adrenergic Blockade in Patients with
Moderate Mitral Stenosis
Brett C. Stoll, Thomas L. Ashcom, Joseph P. Johns, James E. Johnson, Bernard
J. Rubal. Brooke Army Medical Center, Fort Sam Houston. TX 78234-6200
p-blocker therapy remains controversial in patients with mitral stenosis. In
this randomized, double-blinded, crossover, placebo-controlled study, the ef-
fects of atenolol (50 and 100 mglday) were assessed in 15 patients (age =
46 ± 11 yrs) with moderate mitral stenosis (mitral valve area = 1.0 ± 0.4
cm2; NYHA class II-III) at rest (R) and during upright bicycle ergometry IE}.
Doppler-echocardiography was employed to compare heart rate IHR), car-
diac (CI) and stroke volume (SVI) indices, diastolic filling period (DFP), and
peak and mean (Mn Grad) transmitral gradients; a metabolic cart was used
to obtain maximum V02, VC02 and anaerobic threshold (AT). P-blockade
therapy did not improve exercise time, extemal work, max V02 or AT. During
exercise, max V02 and CI decreased (p < 0.05) > 11 % and >20%, respec-
tively, with atenolol. Thefollowing hemodynamic data are presented as mean
±sd:
Sharon Orrange, David Kawanishi, Becky Lopez. Susan Curry,
Shahbudin Rahimtoola. University ofSo. Califorma. Los Angeles. CA
Catheter balloon valvuloplasty (CBV) for mitral stenosis was performed in
132 patients (pts) from 1986 to '94. There were 104 women 179%) and 28
men, aged 44 ± 14 years. Pre-CBV, 12 pts were NYHA Functional Class (FC)
IV, 87 in FC III. 28 FC II and 2 were FC I. CBV increased mitral valve area IMVA)
from 0.98 ± 0.26 to 1.94 ± 0.57 cm2, p < 0.001.
There were 6 early deaths up to 1 month ("procedure-related"); all 4 late
deaths occurred after elective valve replacement (VR) was performed 18.2
± 25 months later. Actuarial 6 yr survival was 83 ± 6% when mortality after
VR is included, excluding these 6 yr survival was 95 ± 1%. Actuarial 1, 3 and
6 yr event-free survival (survival without VR or repeat CBV) were 80 ± 4%,
76 ± 4% and 63 ± 7%. Pre-CBV variables were not significant predictors of
outcome. On multivariate analysis, post-CBV independent predictors of 6 yr
event-free survival were 1) MVA ~1.5 vs < 1.5 cm2, 73 ± 8% vs 32 ± 12%; 2}
Pulmonary artery (PA) wedge .:::18 vs > 18 mmHg, 84 ± 6% vs 38 ± 12%, P
< 0.001 for both. Pts. with MVA ~ 1.5 cm2 In = 96) could be further divided
into high and low-risk subgroups for 6 yr event-free survival by 3 post-CBV
variables: 11 PA wedge .:::18 vs > 18, 90 ± 6% vs 46 ± 15% (p = 0.002); 2)
Mean PA <30 vs ~30, 89 ± 6% vs 54 ± 14% (p = 0.061; 3) Cardiac Index (CI)
~2.5 vs <2.5.82 ± 8% vs 53 ± 17% (p = 0.002). Pts with post-CBV MVA
<1.5 In = 24) had no additional predictors of event-free survival. Of those
pts who did not undergo VR or repeat CBV 94% were FCI or FCII.
Conclusions: CBV for mitral stenosis has good long term results up to 6
yrs. Late deaths were related to elective surgery. 6 yr event-free survival was
very good in pts with post-CBV MVA ~1.5 cm2 especially if PA wedge was
.:::18 or CI was ~2.5.
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Placebo Atenolol
50 mg 100 mg
HR R 76 ± 13 60 ± 11' 58 ± 13'
(bpm) E 144 ± 15 112± 23' 103 ± 21'
DFP R 431 ± 97 604 ± 148' 629 ± 175'
1msec) E 208 ± 35 277 ± 90' 300 ± 95'
SVI R 22 ± 7 22 ± 6 26 ± 8
Imllm2) E 21 ± 10 22 ± 10 26 ± 9
Mn Grad R 5 ± 4 4± 3 4± 2
(mmHg) E 20 ± 8 17± 8 15 ± 8'
'p < 0.05 Placebo vs Atenolol
Although HR and Mn Grad decreased and DFP increased with atenolol,
SVI changed little compared with placebo. The data suggest that in spite of
Late Cardiac Catheterization Results of Catheter
Balloon Commissurotomy for Mitral Stenosis at
Rest and Exercise
DaVid Kawanishi, Becky Lopez, Sharon Orrange, Susan Curry,
Shahbudin Rahimtoola. University ofSouthern California. Los Angeles. CA
Cardiac catheterization (cath) was performed on 132 patients (pts) both pre
and immediately post catheter balloon commissurotomy ICBC). Sixty eight
pt's had cath performed at 3--B months post-CBC and twenty had a late
follow-up cath (mean 3.2 yrs. range 1-7 yrs). At late follow-up cath 16 of the
20 pts were NYHA functional class (FC) I or II; 13 females and 3 males age 40
± 11 yrs, We have reviewed the sequential hemodynamic findings in these
16 pt's to see if hemodynamic improvement achieved by CBC is sustained.
